Daniel Marsh

Daniel Marsh

Senior Markets Analyst

Daniel Marsh is a senior markets analyst at StockTi with over 12 years of experience covering U.S. and global equity markets. He holds a CFA charter and previously worked as an equity research associate at a major Wall Street firm. Daniel specializes in macroeconomic analysis, market trends, and cross-sector investment themes. His work focuses on translating complex market data into actionable insights for individual and institutional investors.

Markets, Economy, Analysis 7,521 articles

Articles by Daniel Marsh

Spirit Airlines Grounds All Flights Amid Funding Crisis, Stranding Over 800,000 Passengers
Markets

Spirit Airlines Grounds All Flights Amid Funding Crisis, Stranding Over 800,000 Passengers

Spirit Airlines shuts down immediately after failing to secure funding, canceling all flights and affecting over 800,000 booked passengers. Competitors step in with discounted fares.

JBLU ULCC
Is Cash Still a Safe Bet? How Inflation Erodes Savings Yields
Economy

Is Cash Still a Safe Bet? How Inflation Erodes Savings Yields

Inflation is outpacing most savings accounts, making cash a costly choice. High-yield options like online banks and I bonds offer better returns.

GLD USO UNG
Wall Street Eyes Three Tech Shifts Beyond AI Chatbots and Nvidia
Markets

Wall Street Eyes Three Tech Shifts Beyond AI Chatbots and Nvidia

S&P 500 and Nasdaq close at record highs as Alphabet, Amazon, Meta, and Microsoft project AI spending above $700B by 2026. Focus shifts to AI infrastructure, robot intelligence, and tokenized securities.

META GOOGL AMZN MSFT COIN COMP
Data Storage Stocks Emerge as Unexpected AI Beneficiaries
Analysis

Data Storage Stocks Emerge as Unexpected AI Beneficiaries

Data storage stocks like Seagate, Sandisk, and Western Digital rally on AI data demand, with Sandisk reporting 251% revenue growth and a $42 billion supply deal.

STX SNDK WDC
May Market Turmoil: 5 Inflation Hedges That Hold Their Ground
Markets

May Market Turmoil: 5 Inflation Hedges That Hold Their Ground

As oil tops $126 and inflation accelerates, short-term Treasuries, TIPS, gold, silver, and select real assets are proving resilient. The Fed's PCE index rose 3.5% year-over-year in March.

GLD SLV USO XLE SPY QQQ XOM CVX
Tech, Energy, and Autos in Focus as Markets Open Amid Inflation Jitters
Markets

Tech, Energy, and Autos in Focus as Markets Open Amid Inflation Jitters

U.S. stocks open at record highs Monday, but March inflation surged and factory input costs hit a four-year peak. Oil prices rose on Strait of Hormuz tensions, while Spirit Airlines ceased operations.

AAPL XLE F GM STLA SPY USO GLD UNG T UAL JBLU ULCC
Nasdaq-100 ETF Up 1.1% as Seagate Surges; Intel and Viavi Also Rally
Markets

Nasdaq-100 ETF Up 1.1% as Seagate Surges; Intel and Viavi Also Rally

The Nasdaq-100 ETF QQQ advanced 1.1% on May 1, driven by a 5.9% jump in Seagate Technology (STX) and strong gains in Apple, Microsoft, and Intel. Viavi Solutions surged 14% on earnings.

QQQ STX AAPL MSFT INTC VIAV FNGR
Nasdaq Breaks 25,000 as S&P 500 Reaches New Peak
Markets

Nasdaq Breaks 25,000 as S&P 500 Reaches New Peak

The S&P 500 and Nasdaq set new records, driven by robust Q1 earnings. GameStop shares rose on reports of a potential eBay offer.

AAPL AMD CRM DIS EBAY GME NOW PLTR RBLX RDDT TEAM
GameStop's $9 Billion War Chest Fuels Stock Rally
Markets

GameStop's $9 Billion War Chest Fuels Stock Rally

GameStop shares climbed to $26.61 as the market speculates on CEO Ryan Cohen's strategy for the company's $9 billion cash pile. Q4 results revealed a sales decline but improved operating income.

GME AMC BBY
Veeva Systems Joins S&P 500, Stock Jumps 10.5%
Markets

Veeva Systems Joins S&P 500, Stock Jumps 10.5%

Veeva Systems shares jumped 10.5% to $172.29 after S&P Dow Jones Indices announced the company will join the S&P 500 on May 7, replacing Coterra Energy.

VEEV DVN CRM IQV
Summit Therapeutics Shares Dive 23% After HARMONi-3 Update Disappoints
Markets

Summit Therapeutics Shares Dive 23% After HARMONi-3 Update Disappoints

Summit Therapeutics shares plummeted 23% after an interim HARMONi-3 update for ivonescimab failed to show early benefit. The trial remains blinded, with final PFS data due in late 2026.

SMMT MRK
Wolfspeed Rallies on Stake Disclosure and Executive Shakeup Ahead of Earnings
Markets

Wolfspeed Rallies on Stake Disclosure and Executive Shakeup Ahead of Earnings

Wolfspeed shares jumped after a group tied to Susquehanna disclosed a 5% stake. New executives and debt refinancing signal turnaround efforts before earnings.

WOLF